OMODEI, Umberto
 Distribuzione geografica
Continente #
NA - Nord America 4.229
AS - Asia 2.153
EU - Europa 1.408
SA - Sud America 423
AF - Africa 109
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.346
Nazione #
US - Stati Uniti d'America 4.186
SG - Singapore 747
CN - Cina 735
UA - Ucraina 541
BR - Brasile 375
HK - Hong Kong 273
DE - Germania 236
IN - India 143
FI - Finlandia 128
IT - Italia 96
FR - Francia 95
GB - Regno Unito 89
TR - Turchia 87
IE - Irlanda 74
RU - Federazione Russa 73
VN - Vietnam 67
NG - Nigeria 61
BD - Bangladesh 29
EE - Estonia 24
AR - Argentina 22
CA - Canada 19
ZA - Sudafrica 19
AU - Australia 17
MX - Messico 15
IQ - Iraq 14
SE - Svezia 11
ES - Italia 9
JP - Giappone 9
SA - Arabia Saudita 8
ID - Indonesia 7
NL - Olanda 7
EC - Ecuador 6
TN - Tunisia 6
BE - Belgio 5
CL - Cile 5
DZ - Algeria 5
EU - Europa 5
LT - Lituania 5
MA - Marocco 5
PL - Polonia 5
CO - Colombia 4
JO - Giordania 4
KE - Kenya 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
IL - Israele 3
PY - Paraguay 3
UY - Uruguay 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
HN - Honduras 2
KR - Corea 2
KZ - Kazakistan 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GR - Grecia 1
GY - Guiana 1
JM - Giamaica 1
LK - Sri Lanka 1
LY - Libia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TO - Tonga 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.346
Città #
Fairfield 473
Woodbridge 464
Ashburn 382
Jacksonville 362
Houston 354
Singapore 353
Ann Arbor 286
Hong Kong 272
Cambridge 215
Seattle 203
Wilmington 191
Beijing 161
San Jose 155
Princeton 146
The Dalles 131
Nanjing 111
Dublin 74
Chandler 71
Los Angeles 70
Istanbul 65
Abuja 61
Lauterbourg 60
Dearborn 53
Helsinki 53
New York 40
São Paulo 33
Nanchang 31
Buffalo 30
San Diego 27
Changsha 26
Milan 26
Ho Chi Minh City 25
Tallinn 24
Redondo Beach 23
Kunming 21
Jiaxing 20
Jinan 20
Hebei 19
Moscow 19
Tianjin 19
Brescia 17
Boardman 16
London 16
Munich 16
Shenyang 16
San Francisco 15
Washington 15
Chennai 14
Rio de Janeiro 14
Santa Clara 14
Shanghai 14
Hanoi 13
Dallas 12
Johannesburg 12
Hangzhou 11
Chicago 10
Kocaeli 10
Orem 10
Belo Horizonte 9
Council Bluffs 9
Manchester 9
Ningbo 9
Tokyo 9
Verona 9
Brooklyn 8
Guangzhou 8
Hefei 8
Sydney 8
Indiana 7
Lanzhou 7
Mexico City 7
Norwalk 7
Nuremberg 7
Atlanta 6
Campinas 6
Caxias do Sul 6
Porto Alegre 6
Zhengzhou 6
Boston 5
Brussels 5
Criciúma 5
Curitiba 5
Des Moines 5
Dhaka 5
Melbourne 5
Mumbai 5
Ribeirão Preto 5
Salvador 5
Sorocaba 5
Stockholm 5
Taiyuan 5
Warsaw 5
Amman 4
Charlotte 4
Fuzhou 4
Montreal 4
Nairobi 4
Orange 4
Phoenix 4
Riverside 4
Totale 5.667
Nome #
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women 181
Can salin infusion sonohysterography (SIS) replace diagnostic hysteroscopy in the uterine cavity evaluation of infertile women? 170
A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: The HOT study 166
Effect of acupuncture on rates of pregnancy among women undergoing in vitro fertilization 165
Clinical Impact of a New Italian Law Regulation on Assisted Reproduction Technologies 159
Effect of soy-derived isoflavones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 158
Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. 155
Chromosome Abnormalities and Yq microdeletions in Infertile italian couples referred for assisted reproductive tecnique 154
FSH receptor polymorphisms in a population of infertile women and controls 148
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Clinical Data 146
Determinants of body mass index in women around menopause attending menopause clinics in Italy. 145
Identification of osteoporosis risk in postmenopausal women by the combined use of ultrasounds and clinical factors 144
Determinants of age at menopause in women attending menopause clinics in Italy. 143
Risk factors for clinically diagnosed uterine fibroids in women around menopause. 143
Effect of soy-derived isoflavones on hot flashes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries 140
General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy 140
A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. 134
Factors associated with total cholesterol levels in women around menopause attending menopause clinics in Italy 134
The Effect of HRT on Endometrial Thickness (ET) and Uterine Arterial Blood Flow Assessed by Transvaginal Ultrasound (TVU). 133
A New HRT Regimen Using Estradiol Valerate and Cyproterone Acetate: Impact on Lipid Metabolism 132
Endometrial thickness and histological abnormalities in women on hormonal replacement therapy: a transvaginal ultrasound/hysteroscopic study 132
Risk identification of osteoporosis in postmenopausal women by a simple algorithm based on ultrasound densitometry and body mass index 132
Serum progesterone level on the day of oocyte retrieval correlates with the ovarian response but not predict pregnancy rate 131
Risk factors for high blood pressure in women attending menopause clinics in Italy. 129
Risk factors for type 2 diabetes in women attending menopause clinics in Italy: a cross-sectional study. 128
Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003. 128
CUMCS: FINDINGS FROM THE ICARUS DATA BASE 126
A new method for free testosterone assay: clinical evaluation. 126
Anti-Mullerian hormone (AMH): Prognostic value in assisted reproductive technology (ART) 126
Risk of low bone density in women attending menopause clinics in Italy 125
Frequency of Cardiovascular Risks Factor in Women Attending Menopause Clinics: Findings from the ICARUS Data Base 125
How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. 124
Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study. 124
Osteoporosis Risk Profile for Peri-and Postmenopausal Women Attending Menopause Clinics in Italy 124
Endometrial Changes and Doppler Flow Evaluation in Postmenopausal Breast Cancer Patients on Tamoxifen (TAM): A Transvaginal Ultrasound (TVU)/Hysterescopy Study 122
Risk of low bone density in women attending menopause clinics in Italy. 121
Ovulation induction with intravenous gonadotropin-releasing hormone 117
Factors associated with climacteric symptoms in women around menopause attending menopause clinics in Italy. 115
Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy 114
A new method for free testosterone assay: clinical evaluation. 110
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 110
Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy. 107
Sequential Conjugated Estrogens Plus Medrogestone HRT Regimen Versus Tibolone: A Comparative Randomized Study 107
EVALUATION OF BLEEDING AND CONTROL OF CLIMACTERIC SYMPTOMS OBSERVED WITH TWO TRANSDERMAL PREPARATIONS CONTAINING ESTRADIOL AND NORETHISTERONE ACETATE 105
The impact of HRT on endometrial thickness—do cut‐off values exist? 104
Continuous combined HRT in post-menopause: two regimen comparative study 104
Profiles and endocrine correlations in endometrial carcinoma. 103
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 103
Doppler flow evaluation of endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen 95
Pituitary microprolactinoma, bromocriptine, and pregnancy: follow-up of 74 cases 93
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 93
The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial 91
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 90
Identificazione del rischio di osteoporosi in donne in postmenopausa mediante l’uso combinato di ultrasuoni e fattori clinici. 90
Endometrial Evaluation in Postmenopausal Bleeding: Transvaginal Sonografy Versus Hysteroscopy 90
La patologia endometriale e la sorveglianza della paziente in postmenopausa 89
Profiles and endocrine correlations in endometrial carcinoma. 88
The effect of HRT on uterine arterial blood flow in postmenopausal women assessed by transvaginal color doppler sonography (TVDS) 87
Effects of Recombinant Follicle-Stimulating Hormone on Bone Turnover Markers in Infertile Women Undergoing in Vitro Fertilization Procedure 84
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 84
Endometrial ultrasound transvaginal (TVU) assessment in postmenopausal women on hormone replacement therapy (HRT) 84
Rischio oncologico 84
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 80
Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen: a transvaginal ultrasound study 79
Outlook on Continuous Estrogen-Progestin Therapy. 77
Premarin 0.625 vs Estraderm TTS 50 Have These Two" Standard Doses" the Same Biological Effects? 77
Treatment of hypothalamic infertility with pulsatile GN-RH administration. 77
Ovarian hyperstimulation syndrome (OHS): a case of severe OHS. 76
Polycystic ovary syndrome: long-term evolution. 75
EFFECTS OF SOY-DERIVED ISOFLAVONES ON HOT FLUSHES AND VASCULAR REACTIVITY 75
Mammella: è possibile la chemioprevenzione? 75
Polycystic ovary syndrome: long-term evolution. 74
Fibrocystic Disease of the Breast Associated with Pituitary‐Ovarian Dysfunction: Results of Treatment with Bromocriptine 66
Totale 8.385
Categoria #
all - tutte 36.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.470


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021219 0 0 0 0 0 0 0 0 0 102 98 19
2021/2022460 14 119 3 28 1 40 27 39 35 52 8 94
2022/2023296 75 1 6 27 20 100 0 19 26 3 6 13
2023/2024378 10 2 35 43 22 46 18 12 103 20 2 65
2024/20251.247 4 1 7 187 134 81 142 19 174 71 300 127
2025/20262.002 217 298 142 278 302 136 320 61 153 95 0 0
Totale 8.385